DNMT3A mutations in AML: a new prognostic factor?

Leuk Res. 2013 Nov;37(11):1432-3. doi: 10.1016/j.leukres.2013.08.012. Epub 2013 Sep 6.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Biomarkers, Tumor / genetics*
  • DNA (Cytosine-5-)-Methyltransferases / genetics*
  • DNA Methyltransferase 3A
  • Humans
  • Leukemia, Myeloid, Acute / genetics*
  • Mutation / genetics*

Substances

  • Biomarkers, Tumor
  • DNMT3A protein, human
  • DNA (Cytosine-5-)-Methyltransferases
  • DNA Methyltransferase 3A